Showing results (401-410 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|January 1, 1985
Measurement of plasma levels of clomipramine in the treatment of chronic painJ L Montastruc, M A Tran, M Blanc, et al.Clinical Neuropharmacology|January 1, 1986
Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observationsW H Poewe, A J Lees, G M SternClinical Neuropharmacology|June 16, 2025
Meta-analysis of Indobufen Combined With Clopidogrel in the Treatment of Ischemic Stroke PatientsWeiwei Yuan, Yan ShaoClinical Neuropharmacology|November 14, 2025
Electroconvulsive Therapy for Refractory Anxiety and Depression in Superficial Siderosis: A Case ReportGregory Pierpoint, Krishan SainiClinical Neuropharmacology|September 19, 2013
Visual hallucinations during duloxetine treatment in a patient with major depressive disorderTetsu Tomita, Norio Yasui-Furukori, Sunao KanekoClinical Neuropharmacology|January 22, 2013
Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy centerEun Hye Lee, Mi-Sun Yum, Hae-Won Choi, et al.Clinical Neuropharmacology|January 22, 2013
First case of lacosamide-induced psychosisDimitrios Chatzistefanidis, Eleni Karvouni, Athanassios P Kyritsis, et al.Clinical Neuropharmacology|January 22, 2013
Lamotrigine augmentation in premenstrual dysphoric disorder: a case reportGianna Sepede, Giovanni Martinotti, Francesco Gambi, et al.Clinical Neuropharmacology|May 16, 2013
Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical studyJoseph Bergman, Chanoch Miodownik, Yuly Bersudsky, et al.Clinical Neuropharmacology|May 16, 2013
Pharmacokinetic considerations for the use of levodopa in the treatment of Parkinson disease: focus on levodopa/carbidopa/entacapone for treatment of levodopa-associated motor complicationsThomas MüllerPageof 236